Sand Hill Angels

Sand Hill Angels is an angel group that was founded in 2 and is headquartered in Sunnyvale California. The group focuses on investments in early-stage (from seed to series C) companies in the Life Sciences IT Internet and Clean Tech sectors. The group prefers to make equity and convertible notes investments and the typical investment size ranges from $.1million to $.5million. The group will consider syndicating with other investors for larger investments. The group will consider companies across the US.
Stephen Pollitt
Board Member Membership Chair 

Science Futures

Science Futures Management is an investment firm based in California USA. In the Life Sciences the firm focuses on biotech therapeutics and diagnostics. The firm typically provides series A financing (equity) in the range of $25K to $5K. The firm is geographically agnostic but generally invests in companies based in the USA and Europe. The firm has no current mandate for the number of allocations it plans to make and will evaluate relevant opportunities as they surface.
Nola Masterson
Managing Director 

SENS Research Foundation, Inc. United States

SENS Research Foundation is based in Mountain View, CA. The foundation provides grants for research into rejuvenation biotechnologies that prevent or reverse age-related tissue damage. Historically grants have ranged from $40,000 to $200,000 although this range may change in the future. Grants are available to researchers worldwide. SENS requests that grants not be used to cover overhead/facilities costs. At present, 15 projects are being supported.

Mike Kope
CEO and President 
Ms Jerri Barrett
VP of Outreach 

Sofia Angel Fund United States

Sofia Angel Group is a group of angel investors based in Minneapolis, Minnesota. The group solely focuses on investing in women-led businesses where women are the founders, or women are on the senior management team. Sofia Angel Group does not have a specific timeframe to make an investment, however would make an allocation by the end of 2013 if a compelling opportunity is identified. The group typically invests around $100,000 per company, however has the ability to invest up to $3 million through co-investments from the group’s members.

Barbara Nelsen

Sound Affects

Sound Affects is a philanthropic organization based in Westport CT. Sound Affects is a nonprofit crowdfunding platform that will provide non-dilutive research grants to for-profit life science companies developing products in the oncology sector. Sound Affects? grant sizes are variable depending on project needs with current projects seeking to raise between $5 and $5, the amount of funding sought should be sufficient to reach the next product development milestone. Sound Affects is potentially open to funding about 4 further projects and is best placed to work with entrepreneurs based in the Northeast/Mid-Atlantic region of the USA but is also open to proposals from outside this region. In addition to direct crowdfunding Sound Affects will in the future provide additional resources via a matching fund.
Mona Jhaveri
Executive Director 

Syncona Partners United Kingdom

Syncona Partners, founded in 2012, is an evergreen investment firm based in London, UK. The firm is an independent subsidiary of the Wellcome Trust who invested the initial £200m capitalization. The firm is mandated to invest in companies with the potential to make major breakthroughs in healthcare. The investment size will usually range from £1M – £20M per company. The firm seeks to create sustainable, profitable businesses, to support them with capital over the long term, for the benefit of patients, and to hold an ownership position to create value for the Wellcome Trust. The firm is actively screening new investment opportunities.

Year Founded
2012
Biotech Phase of Development
Medtech Phase of Development
Capital Structure Preference
Investment Stage Preference
Chris Hollowood
Partner 

Tech Coast Angels

Founded in 1997, Tech Coast Angels is the largest angel investor group in the United States. Its members provide funding and guidance to more early-stage high-growth companies in Southern California than any other investment group. TCA members invest in companies in a wide range of industries including life sciences, biotech and health IT. TCA has more than 325 members including its venture capital affiliates in five networks in Los Angeles Orange County San Diego Westlake/Santa Barbara and the Inland Empire. The organization will finance on an opportunistic basis as long as substantial disruptive market opportunities exists. The firm has historically invested in Biotech Therapeutics & Diagnostics, Biotechnology R&D Services, Biotechnology Other, Medical Technology companies with sub sectors of Anti-Infectives, Bioinformatics, CRO (Contract Research Organization), Diagnostic Instrumentation, Diagnostic Services, Drug Delivery, Food, Industrial Biotechnology, Small Molecules, Small Molecule Therapeutics, Wound Care and indications including Diseases of the Nervous System, Infectious and Parasitic Diseases, Neoplasms/Cancer/Oncology, Respiratory.

Websites:
www.greenwingsbiomedical.com
techcoastangels.com

Investor Type
Biotech Phase of Development
Medtech Phase of Development
Capital Structure Preference
Investment Stage Preference
Richard Koffler
Member 

Twin Cities Angels Fund II, LLC United States

Twin Cities Angels is an angel group that was founded in 2006 that is based in Minnesota. The group has raised two funds that are The Twin Cities Angels Fund I and II. The second fund is currently looking to invest in emerging companies. The group typically provides seed and venture capital ranging from $ 25.000 to $2 million to life science companies. The group plans to invest in 4 to 6 companies per year. Twin Cities Angels seeks to invest in companies based in the Twin Cities Area of Minneapolis/St. Paul, the state of Minnesota and within a reasonable distance, such as Western Wisconsin, Northern Iowa, and Eastern Dakotas.

Year Founded
2006
Investor Type
Biotech Phase of Development
Medtech Phase of Development
Capital Structure Preference
Investment Stage Preference
John Alexander
Chairman & Founder 

TYLT Lab

TYLT Lab was founded in 213 and has offices in Santa Monica CA and in Hong Kong. TYLT Lab invests across a variety of sectors including biotech and medical technology and will be raising a second fund in 215. TYLT Lab typically invests $5-$1 million and prefers to invest in seed or Series A rounds. The firm makes up to 12 allocations per year and is interested in opportunities globally, companies developing products that can impact healthcare delivery in emerging markets such as China or India are of particular interest.
Gerard Casale
Managing Director 

Ventac Partners United States

Ventac Partners is a dedicated life science investment and consulting firm with offices in Europe, USA and Asia. Ventac Partners has a strong track record in founding new innovative companies, fund raising and supporting M&A transactions.

All partners are experienced and hands-on life science entrepreneurs with proven track-record in successfully starting, funding, growing and expanding international life science companies.

Neil Thomas
Neil Thomas
LinkedIn logo Partner